Balyasny Asset Management
NXTM

Balyasny Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Balyasny Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-184,204
Closed -$5.27M – 1801
2018
Q4 		$5.27M Buy
184,204
+164,851
+852% +$4.68M 0.04% 497
2018
Q3 		$540K Buy
+19,353
New +$544K ﹤0.01% 1351
2018
Q1 		– Sell
-14,036
Closed -$340K – 2510
2017
Q4 		$340K Buy
14,036
+4,807
+52% +$127K ﹤0.01% 1695
2017
Q3 		$255K Sell
9,229
-7,367
-44% -$196K ﹤0.01% 1603
2017
Q2 		$416K Buy
+16,596
New +$411K ﹤0.01% 1258
2016
Q3 		– Sell
-10,566
Closed -$229K – 1404
2016
Q2 		$229K Buy
+10,566
New +$189K ﹤0.01% 992
2016
Q1 		– Sell
-33,890
Closed -$743K – 1646
2015
Q4 		$743K Buy
+33,890
New +$632K 0.01% 755
2015
Q3 		– Sell
-26,080
Closed -$373K – 1502
2015
Q2 		$373K Buy
26,080
+15,220
+140% +$258K ﹤0.01% 918
2015
Q1 		$188K Buy
+10,860
New +$192K ﹤0.01% 859

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Balyasny Asset Management's NXTM Position: Q1 2019 in Review

Balyasny Asset Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 184,204 shares — an estimated $5.27M sold.

Balyasny Asset Management first reported a position in NXTM in Q1 2015 and held it in 9 quarters. The position peaked at $5.27M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Balyasny Asset Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Balyasny Asset Management sold 184,204 NxStage Medical Inc. shares in Q1 2019, an estimated $5.27M.
  • Balyasny Asset Management first reported a position in NxStage Medical Inc. in Q1 2015 and held it in 9 quarters.
  • Balyasny Asset Management's NxStage Medical Inc. position peaked at $5.27M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Balyasny Asset Management's 13F filing for Q1 2019, filed 15 May 2019.